4. 標靶治療藥物Tyrosine kinase inhibitor, Imatinib, 對下列何種急性淋巴芽細胞白血病(ALL)有效？ (A) B-lineage ALL with t(9;22) (B) B-lineage ALL with t(4;11) (C) CD19 positive B-lineage ALL (D) CD20 positive B-lineage ALL (E) CD3 positive T-lineage ALL